For SF-36v2, the general health, mental health, role-physical, and vitality domain scores and PCS score improved in an increasing trend across the weight reduction target groups (≥ 5 to ≥ 30%).
← all excerpts
Tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial.
1
—
—